Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT+ B-cell lymphoblastic lymphoma/leukemia.
Transformation of follicular lymphoma (FL) into B-cell lymphoblastic lymphoma/leukemia (LL) is rare and results in greatly increased aggressiveness of clinical course. Here we present extensive molecular analysis of this unusual transformation, including immunoglobulin (Ig) gene rearrangement studies, cytogenetic analysis, and whole exome sequencing (WES) of the patient's FL, LL, and normal cells. While FL showed marked somatic hypermutation (SHM) of the Ig genes, SHM appeared to be even more extensive in LL. Cytogenetically, four translocations were identified in the LL: two involving BCL-2, and one each in BCL-6 and c-MYC genes, with two of these, the BCL-6 and one of the BCL-2 gene rearrangements, already seen at the FL stage. WES identified 751 single nucleotide variants with high allelic burden in the patient's cells, with the vast majority (575) present exclusively at the LL stage. Of note, a TAF3 gene mutation was shared by normal, FL and LL tissue, perhaps predisposing this young patient to develop FL. In turn, the KMT2D nonsense mutation was identified in both FL and LL, and therefore may have contributed directly to lymphomagenesis. Mutations in KDM6A, SMARCA4, CBX1, and JMY were specific to the LL stage, possibly contributing to the LL transformation. Functionally, these identified mutations may lead to dysregulation of DNA repair, transcription, and cell differentiation. Thus, these genetic changes, together with the identified chromosomal translocations, may have contributed to lymphoma development and progression. Our findings may improve the mechanistic understanding of the FL-LL transformation, and may have therapeutic implication for this aggressive disease.